Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
To demonstrate the difference between Abilify with Depakote vs. Placebo with Depakote in
24-week treatment in patients with remission status after Abilify with Depakote in the 6-week
study of acute mania in patients with bipolar disorder